Jevtana Related Clinical Trials
Cabazitaxel - PF Induction Chemotherapy [Completed]
Cabazitaxel vs. Vinflunine in Metastatic or Locally Advanced Transitional Cell Carcinoma of the Urothelium (TCCU) [Recruiting]
Cabazitaxel in Men 75 Years of Age or Older With Castration-Resistant Prostate Cancer [Withdrawn]
Study of Weekly Cabazitaxel for Advanced Prostate Cancer [Active, not recruiting]
Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer [Recruiting]
Cabazitaxel With or Without Carboplatin in Patients With Metastatic Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Therapy [Active, not recruiting]
Ph Ib/IIa Study of Cabazitaxel Plus Bavituximab in Castration-resistant Prostate Cancer [Terminated]
Phase I/II Cabazitaxel for Recurrent Malignant Glioma [Withdrawn]
Dose-Escalation, Safety, Pharmacokinetics Study of Cabazitaxel With Gemcitabine In Patients With Solid Tumor [Terminated]
Study of the Effect of Chemotherapy With Cabazitaxel on Prostate Cancer [Recruiting]
A Phase III of Cabazitaxel and Pelvic Radiotherapy in Localized Prostate Cancer and High-risk Features of Relapse [Recruiting]
Cabazitaxel in Patients With Urothelial Carcinoma Who Have Disease Progression Following Platinum-Based Chemotherapy [Active, not recruiting]
Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Hormone-Resistant Prostate Cancer [Recruiting]
Cabazitaxel Plus Lapatinib as Therapy for HER2-Positive Metastatic Breast Cancer Patients With Intracranial Metastases [Recruiting]
Ph II Cabazitaxel/Ifosfamide DD Liposarcoma [Recruiting]
Phase I Cabazitaxel, Mitoxantrone, and Prednisone Metastatic Castration-Resistant Prostate Cancer [Recruiting]
Cabazitaxel vs Abiraterone or Enzalutamide in Patients With Poor Prognosis Metastatic Castration-resistant Prostate Cancer [Recruiting]
Phase II-b Randomized Clinical Trial of Cabazitaxel in Metastatic Colorectal Cancer Resistant to Standard Treatment [Terminated]
A Trial of Cabazitaxel for Advanced Transitional Cell Carcinoma (TCC) [Completed]
Testis CAB: Cabazitaxel as Salvage Treatment for Cisplatin-resistant Germ Cell Cancer [Recruiting]
The JET Study: a Phase I Trial of Cabazitaxel, Radiotherapy and Long-term Androgen Deprivation [Withdrawn]
Safety and Efficacy of Cabazitaxel in Pediatric Patients With Refractory Solid Tumors Including Central Nervous System Tumors [Recruiting]
Phase II Study of Cabazitaxel-XRP6258 in Advanced Non-Small Cell Lung Cancer [Active, not recruiting]
Evaluation of Cabazitaxel in Patients With Brain Metastasis Secondary to Breast Cancer and NSCLC [Withdrawn]
Study of Cabazitaxel in Patients With Metastatic Breast Cancer Previously Treated With Taxanes [Recruiting]
A Study to Evaluate the Effects of Combining Cabazitaxel With Cisplatin Given Every 3 Weeks in Patients With Advanced Solid Cancer [Completed]
Evaluation of Safety of Cabazitaxel (Jevtana) in Patients With Metastatic Hormone Refractory Prostate Cancer [Active, not recruiting]
A Dose Finding Study of XRP6258 in Patients With Advanced Solid Tumors [Completed]
A Study Looking at Novel Scheduling of Cabazitaxel for Patients With Metastatic Prostate Cancer [Recruiting]
Treatment of Locally Advanced or Metastatic Transitional Cell Carcinoma With Cabazitaxel [Recruiting]
Cabazitaxel and BKM120 in Patients With Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel [Withdrawn]
Bristol Bladder Trial [Recruiting]
CLUBNET-CABAZ_L_06639 Neoadjuvant Chemotherapy With Cabazitaxel [Recruiting]
Cabazitaxel and Radiation For Patients With Pathologically Determined Stage 3 Prostate Cancer and/or Patients With PSA Elevation (>0.1- < 2.0 ng/mL) [Terminated]
Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel [Terminated]
XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate Cancer [Completed]
A Study of Cabazitaxel for Patients With Breast or Lung Cancer and Recurrent or Progressive Brain Metastases - Cabazitaxel for Brain Metastases (CaBaMet) [Not yet recruiting]
Phase II Study of Cabazitaxel in Refractory Metastatic Gastric or Gastroesophageal Adenocarcinoma [Active, not recruiting]
Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or Enz [Recruiting]
Cabazitaxel Versus the Switch to Alternative AR-targeted Agent (Enzalutamide or Abiraterone) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Patients Previously Treated With Docetaxel and Who Rapidly Failed a Prior AR-targeted Agent [Not yet recruiting]
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen [Completed]
Chemotherapy for Patients With Gastroesophageal Cancers Who Have Progressed After One Prior Chemo Regimen [Terminated]
Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer [Completed]
Pharmacokinetics and Safety Study of Cabazitaxel in Cancer Patients With Renal Impairment [Completed]
Cabazitaxel in Relapsed and Metastatic NSCLC [Active, not recruiting]
Effect of Cabazitaxel on the QTc Interval in Cancer Patients [Completed]
Comparison of Cabazitaxel/Prednisone Alone or in Combination With Custirsen for 2nd Line Chemotherapy in Prostate Cancer [Active, not recruiting]
Study With Cabazitaxel in Previously Treated Patients With Advanced or Metastatic Gastric Cancer [Recruiting]
Cabazitaxel in Platinum Refractory Ovarian Cancer [Terminated]
Cabazitaxel and Abiraterone Acetate in Patients With Metastatic Castrate-Resistant Prostate Cancer [Completed]
Patient Preference Between Cabazitaxel and Docetaxel in Metastatic Castrate-resistant Prostate Cancer [Recruiting]
Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in Treatment of Metastatic Castration Resistant Prostate Cancer [Recruiting]
Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA [Terminated]
Study Comparing Two Treatments in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck [Completed]
Cabazitaxel in Asian Patients With Advanced Gastric Cancer Who Failed Prior Chemotherapy [Completed]
A Prospective Study of Cabazitaxel in Patients With Non Seminomatous Germ-cell Tumors [Recruiting]
Cabazitaxel at 20 mg/m² Compared to 25 mg/m² With Prednisone for the Treatment of Metastatic Castration Resistant Prostate Cancer [Active, not recruiting]
Cabazitaxel Versus Docetaxel Both With Prednisone in Patients With Metastatic Castration Resistant Prostate Cancer [Active, not recruiting]
A Phase II, Open-Label, Multicenter Trial of Cabazitaxel in Patients With Recurrent or Metastatic Head and Neck Cancer After Failure Of Cisplatin, Cetuximab and Taxanes [Active, not recruiting]
Continued Treatment With Docetaxel Versus Switch to Cabazitaxel After Minor Prostate Specific Antigen Response to Docetaxel in Patients With Castration-Resistant Metastatic Prostate Cancer [Completed]
Dose Escalation Study With Cabazitaxel in Combination With Daily Prednisolone in Patients With Hormone Refractory Prostate Cancer [Completed]
Efficacy and Safety of Cabazitaxel Versus Weekly Paclitaxel as Neo-adjuvant Treatment in Patients With Triple Negative or Luminal B/HER2 Normal BC (GENEVIEVE) [Recruiting]
Efficacy Study Evaluating Chemotherapy in Prostate Cancer [Recruiting]
The CATCH Prostate Cancer Trial: Cabazitaxel And Tasquinimod in Men With Prostate Cancer [Active, not recruiting]
Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors [Active, not recruiting]
PROSTAC: Multicentre Biomarker Study in CRPC Treated With Chemotherapy [Recruiting]
Second-line Chemotherapy in Castration Resistant Prostate Cancer [Recruiting]
Efficacy Trial of the Implantation of Mouse Renal Adenocarcinoma Macrobeads in Subjects With Castration-Resistant Prostate Cancer Resistant to Taxanes (Docetaxel, Cabazitaxel) and Evidence of Disease Progression on Androgen-axis Inhibition and/or Immunotherapy in the Form of Sipuleucel-T [Recruiting]
A Study Evaluating the Pain Palliation Benefit of Adding Custirsen to Docetaxel Retreatment or Cabazitaxel as Second Line Therapy in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC) [Terminated]
Pharmacogenetic Study in Castration-resistant Prostate Cancer Patients Treated With Abiraterone Acetate [Recruiting]
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC) [Completed]
GEMOX in Docetaxel-Refractory Castration-Resistant Prostate Cancer [Completed]
Analyze the Predictive Value of Gene TMPRSS2-ETS in Response to Enzalutamide in Patients With Prostate Cancer [Not yet recruiting]
|